Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04140903 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Partial Oral Antibiotic Treatment for Bacterial Brain Abscess

Study acronym: ORAL
StatusRecruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary completion date: Aug 31, 2024 to Aug 31, 2028
    • Study completion date: Aug 31, 2025 to Aug 31, 2028
    v6
  2. Re-verified, no change to tracked fieldsv5
  3. Primary completion date: Aug 31, 2023 to Aug 31, 2024
    • Study completion date: Aug 31, 2024 to Aug 31, 2025
    v4
  4. Study sites: 2 to 4v3
  5. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 2
    • Start date changed from estimate of Sep 1, 2020 to Nov 6, 2020
    v2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The investigators aim to determine if oral antibiotics are clinically acceptable as treatment of brain abscess. Following 2 weeks of standard intravenous antibiotic therapy, half of patients will continue with this treatment for another 4 weeks or longer while the other half will be assigned to oral antibiotics for the remaining duration of treatment.
Trial Details
NCT Number NCT04140903
Lead Sponsor Henrik Nielsen
Conditions
(from sponsor)		 Brain Abscess, Cerebral Abscess
Related terms Brain Abscess
Enrollment 400 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov